Literature DB >> 28617178

Concentrations of Pneumococcal IgA and IgM are compromised in some individuals with antibody deficiencies.

Ainara Echeverría de Carlos1, Ricardo Gómez de la Torre2, Enrique García Carus2, Luis Caminal Montero2, Jose Bernardino Díaz López2, Hector Suárez Casado3, Luis Molinos Matin4, Lourdes Tricas Aizpún1, Stephen Harding5, Antony R Parker5.   

Abstract

The response to pneumococcal vaccination is assessed by measurement of antigen specific IgG only and is compromised in a number of antibody deficiencies. We measured the concentrations of Pneumococcal IgA and IgM in individuals with both normal and abnormal pneumococcal capsular polysaccharide (PCP) IgG concentrations. A higher number of individuals had abnormal pre-vaccination IgA and IgM concentrations below the lower limit of the normal range compared to the control group. Post vaccination a lower number of individuals had IgA and IgM concentrations below the upper limit of the normal range compared to the control group. Non responders had a higher percentage of individuals with a prior history of infection. In addition, individuals with a history of prior infection had lower pre- and post-vaccination concentrations of PCP IgG, IgA, and IgM. Post-vaccination IgA and IgM concentrations identified four groups of responses which correlated with prior history of infection. A higher percentage of individuals with abnormal PCP IgA and IgM concentrations had a history of prior infection compared to the percentage of individuals with normal concentrations. In individuals with an antibody deficiency, measurement of Pneumococcal IgA and IgM correlates with the number of individuals with prior history of infection.

Entities:  

Keywords:  IgA; IgM; Pneumococcal; antibody deficiency; pneumovax

Mesh:

Substances:

Year:  2017        PMID: 28617178     DOI: 10.1080/15321819.2017.1337641

Source DB:  PubMed          Journal:  J Immunoassay Immunochem        ISSN: 1532-1819


  1 in total

1.  The clinical relevance of IgM and IgA anti-pneumococcal polysaccharide ELISA assays in patients with suspected antibody deficiency.

Authors:  Lisanne M A Janssen; Michiel Heron; Jean-Luc Murk; Alexander C A P Leenders; Ger T Rijkers; Esther de Vries
Journal:  Clin Exp Immunol       Date:  2021-06-01       Impact factor: 4.330

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.